Rocket VR Well being introduced its participation in Newchip’s world accelerator programme designed to fund, construct, and scale startups and corporations.
The Newchip Seed Accelerator gives Rocket VR Well being with trade specialists, mentors, and advisors that personally help with the immersive agency’s world development, Nik Vassev, COO and Co-Founding father of Rocket VR Well being, defined in a press release
He added,
“This partnership will enable us to proceed creating progressive instruments for sufferers at each step of their most cancers journey”
Newchip’s digital accelerator scheme targets greater than 1,500 founders and companies, and the corporate will present roughly $450 million USD in funding to construct a portfolio price roughly $9 billion.
Newchip’s seed funding will assist the healthcare agency generate traction and income. Armando Vera Carvajal, the Vice President of Product at Newchip added,
“Progressive healthcare expertise firms like Rocket VR Well being can scale shortly with correct funding and steering. We’re excited for Rocket VR Well being and imagine they are going to be effectively positioned to benefit from our fast-expanding world ecosystem at Newchip”
Immersive, Participating Healthcare
Rocket VR Well being is creating an immersive healthcare answer which distributes digital therapeutic programs to most cancers sufferers and survivors.
The Rocket VR Well being product utilises Pico Interactive headsets from dad or mum firm ByteDance to offer sufferers with wealthy therapeutic companies.
It was nice to affix all of the main #VR innovators and neighborhood at our very first convention #AWE2022 pic.twitter.com/KZbe9OA4UK
— Rocket VR Well being (@RocketVRHealth) June 4, 2022
Rocket VR Well being’s immersive remedy lasts 4 weeks and it provides sufferers present process transplant remedy and social isolation with participating immersive actions to help with restoration durations.
The service additionally incorporates outdoor-styled VR environments the place sufferers can get pleasure from digital actions akin to gaming, wellness, and on-demand remedy.
The information comes after the Massachusetts Common Hospital partnered with Rocket VR Well being in March to co-develop scientific therapies for most cancers sufferers.
The partnership additionally helps the event of immersive options for sufferers present process hematopoietic stem cell transplantation (HCT) therapies.
HCT sufferers typically turn out to be bedridden, and Rocket VR Well being’s product goals to enhance the standard of life for these people present process HCT therapies on the Massachusetts location.
